z-logo
open-access-imgOpen Access
Pharmacoeconomic analysis of using benralizumab for treatment of severe asthma in inpatient and outpatient settings
Author(s) -
М. В. Журавлева,
S. N. Avdeev,
Yu. V. Gagarina,
Т. В. Марин
Publication year - 2022
Publication title -
farmakoèkonomika
Language(s) - English
Resource type - Journals
eISSN - 2070-4933
pISSN - 2070-4909
DOI - 10.17749/2070-4909/farmakoekonomika.2022.143
Subject(s) - medicine , benralizumab , pharmacoeconomics , emergency medicine , pediatrics , intensive care medicine , medical emergency , asthma , mepolizumab , eosinophil

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here